June 4, 2025 - The International Council of Biotechnology Associations (ICBA), of which the Japan Bioindustry Association (JBA) is one of members, has released a global statement calling for strengthened international cooperation to build resilient biopharmaceutical supply chains.
The ICBA statement, representing 33 national biotechnology associations worldwide, emphasizes that maintaining open and predictable trade is essential for global public health and innovation. The document highlights the inherently global nature of biotechnology supply chains and the need for coordinated international action.
The statement outlines key recommendations including strengthening cross-border collaboration, building supply chain redundancy through diversified sourcing, enhancing regulatory cooperation, and supporting small biotech companies that drive innovation.
Read the full ICBA statement: [Link to ICBA document]
